These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 15987350)

  • 1. The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion.
    Kleinman SH; Glynn SA; Higgins MJ; Triulzi DJ; Smith JW; Nass CC; Garratty G; Murphy EL; LeParc GF; Schreiber GB; King MR; Chamberland ME; Nemo GJ
    Transfusion; 2005 Jul; 45(7):1073-83. PubMed ID: 15987350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RADAR repository: providing a prospective perspective on the past.
    Benjamin RJ
    Transfusion; 2005 Jul; 45(7):1051-3. PubMed ID: 15987346
    [No Abstract]   [Full Text] [Related]  

  • 3. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group.
    Sullivan MT; Williams AE; Fang CT; Grandinetti T; Poiesz BJ; Ehrlich GD
    Arch Intern Med; 1991 Oct; 151(10):2043-8. PubMed ID: 1929693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of a blood donation archive repository: international survey of donor repository procedures and Scottish experiences.
    Franklin IM; Dow BC; Jordan AD
    Transfusion; 2007 Jul; 47(7):1172-9. PubMed ID: 17581151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of multiple donor exposure blood recipients: surveillance value and limitations for hemovigilance.
    Zou S; Wu Y; Cable R; Dorsey K; Tang Y; Hapip CA; Melmed R; Trouern-Trend J; Carrano D; Champion M; Fujii K; Fang C; Dodd R
    Transfusion; 2010 Jan; 50(1):128-38. PubMed ID: 19778336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lookback study of HTLV-1 and 2 seropositive donors and their recipients in Belo Horizonte, Brazil.
    Namen-Lopes MS; Martins ML; Drummond PC; Lobato RR; ; Carneiro-Proietti AB
    Transfus Med; 2009 Aug; 19(4):180-8. PubMed ID: 19706135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.
    Spinella PC; Perkins JG; Grathwohl KW; Repine T; Beekley AC; Sebesta J; Jenkins D; Azarow K; Holcomb JB;
    Crit Care Med; 2007 Nov; 35(11):2576-81. PubMed ID: 17828033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.
    Stramer SL; Foster GA; Dodd RY
    Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
    Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
    Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood safety strategies for human T-cell lymphotropic virus in Europe.
    Laperche S; Worms B; Pillonel J; ;
    Vox Sang; 2009 Feb; 96(2):104-10. PubMed ID: 19076337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
    Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.
    Zou S; Musavi F; Notari EP; Fujii KE; Dodd RY;
    Transfusion; 2005 Oct; 45(10):1593-600. PubMed ID: 16181210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood collection and transfusion in the United States in 1999.
    Sullivan MT; Wallace EL
    Transfusion; 2005 Feb; 45(2):141-8. PubMed ID: 15660821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety.
    Zou S; Fujii K; Johnson S; Spencer B; Washington N; Iv EN; Musavi F; Newman B; Cable R; Rios J; Hillyer KL; Hillyer CD; Dodd RY;
    Transfusion; 2006 Nov; 46(11):1997-2003. PubMed ID: 17076856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
    Van der Bij AK; Coutinho RA; Van der Poel CL
    Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006.
    Polizzotto MN; Wood EM; Ingham H; Keller AJ;
    Transfusion; 2008 Jan; 48(1):55-63. PubMed ID: 17894794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.